These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9832297)

  • 1. Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone.
    Cohen O; Zylber-Katz E; Caraco Y; Granit L; Levy M
    Eur J Clin Pharmacol; 1998 Sep; 54(7):549-53. PubMed ID: 9832297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators.
    Levy M; Safadi R; Zylber-Katz E; Granit L; Caraco Y
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):461-5. PubMed ID: 11699610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation and excretion of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1992; 42(2):187-91. PubMed ID: 1618251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma kinetics of dipyrone metabolites in rapid and slow acetylators.
    Levy M; Flusser D; Zylber-Katz E; Granit L
    Eur J Clin Pharmacol; 1984; 27(4):453-8. PubMed ID: 6519153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1985; 29(1):67-71. PubMed ID: 4054207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
    Caraco Y; Zylber-Katz E; Granit L; Levy M
    Arzneimittelforschung; 1993 Nov; 43(11):1204-8. PubMed ID: 8292065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dipyrone, acetylsalicylic acid and acetaminophen on human neutrophil chemotaxis.
    Matzner Y; Drexler R; Levy M
    Eur J Clin Invest; 1984 Dec; 14(6):440-3. PubMed ID: 6441720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyrone metabolite 4-MAA induces hypothermia and inhibits PGE2 -dependent and -independent fever while 4-AA only blocks PGE2 -dependent fever.
    Malvar Ddo C; Aguiar FA; Vaz Ade L; Assis DC; de Melo MC; Jabor VA; Kalapothakis E; Ferreira SH; Clososki GC; de Souza GE
    Br J Pharmacol; 2014 Aug; 171(15):3666-79. PubMed ID: 24712707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of dipyrone metabolites in human breast milk.
    Zylber-Katz E; Linder N; Granit L; Levy M
    Eur J Clin Pharmacol; 1986; 30(3):359-61. PubMed ID: 3732376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of antipyrine metabolites in human plasma by solid-phase extraction and micellar liquid chromatography.
    Carretero I; Vadillo JM; Laserna JJ
    Analyst; 1995 Jun; 120(6):1729-32. PubMed ID: 7604956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profiles of the active metamizole metabolites after four different routes of administration in healthy dogs.
    Giorgi M; Łebkowska-Wieruszewska B; Lisowski A; Owen H; Poapolathep A; Kim TW; De Vito V
    J Vet Pharmacol Ther; 2018 Jun; 41(3):428-436. PubMed ID: 29352476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium.
    Vlahov V; Badian M; Verho M; Bacracheva N
    Eur J Clin Pharmacol; 1990; 38(1):61-5. PubMed ID: 2328750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent pharmacokinetics of metabolites of dipyrone in saliva.
    Neddermann E; Rohdewald P
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):105-11. PubMed ID: 3208789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyrone metabolism in liver disease.
    Zylber-Katz E; Caraco Y; Granit L; Levy M
    Clin Pharmacol Ther; 1995 Aug; 58(2):198-209. PubMed ID: 7648770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age on the pharmacokinetics of dipyrone.
    Zylber-Katz E; Granit L; Stessman J; Levy M
    Eur J Clin Pharmacol; 1989; 36(5):513-6. PubMed ID: 2753071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profiles of the two major active metabolites of metamizole (dipyrone) in cats following three different routes of administration.
    Lebkowska-Wieruszewska B; Kim TW; Chea B; Owen H; Poapolathep A; Giorgi M
    J Vet Pharmacol Ther; 2018 Apr; 41(2):334-339. PubMed ID: 29164623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic assay for metamizol metabolites in rat plasma: application to pharmacokinetic studies.
    Domínguez-Ramírez AM; Calzadilla PC; Cortés-Arroyo AR; Hurtado Y de la Peña M; López JR; Gómez-Hernández M; López-Muñoz FJ
    J Pharm Biomed Anal; 2012 Dec; 71():173-8. PubMed ID: 22917546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of dipyrone in man; role of the administration route.
    Asmardi G; Jamali F
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):121-5. PubMed ID: 4043141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thin-layer chromatographic determination of major metamizole metabolites in serum and urine.
    Sistovaris N; Pola W; Wolhoff H
    J Chromatogr; 1983 May; 274():289-98. PubMed ID: 6874829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative thin-layer chromatographic estimation of aminophenazone (I.N.N.), 4-methylaminophenazone and 4-aminophenazone in plasma (author's transl)].
    Hüller G; Haustein KO
    Pharmazie; 1981 Aug; 36(8):546-8. PubMed ID: 7291286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.